For media inquiries email [email protected]
Before we dive into stories of our day-to-day research, we think it’s worth sharing why we have such deep conviction that constrained alpha-helical (Helicon) peptides will be unique and impactful medicines.
Parabilis Chief Business Officer Greg Miller joined the “Fierce 15 – Where are they now?” panel at Fierce Biotech Week – a check in with leaders from companies previously recognized by Fierce as the most promising emerging biotechs pushing the boundaries of science. During the panel, Greg and fellow life science leaders explored topics including partnerships and how companies are building their business models in today’s market. The panel was recorded and published on Fierce’s “The Top Line” podcast.